Titan Pharmaceuticals to Offer More Shares of Common Stock

Titan Pharmaceuticals (NASDAQ: TTNP) has filed preliminary paperwork with the SEC in which they have announced their plans to register more shares for the public market. Each share of common stock being registered is being sold together with a warrant to purchase another share of common stock that will be exercisable at a later date. As of right now, there is no word as to the exercise price of the warrants, nor is there any word regarding how many stocks are being registered. What is known, however, is that the proposed maximum aggregate price offering of this deal is $11,442,750. Maxim Group LLC is serving as the sole-bookrunner for this deal. There is no word as of yet to the underwriters' discount.

Use of Proceeds

In their prospectus, Titan Pharmaceuticals declared how they inte...

Login In


Register now for free access

Notify of
Inline Feedbacks
View all comments